Estrogen receptor (ER) and progesterone receptor (PgR), by ligandbinding assay compared with ER, PgR and pS2, by immunohistochemistry in predicting …
RM Elledge, S Green, R Pugh, DC Allred… - … journal of cancer, 2000 - Wiley Online Library
Results of estrogen receptor (ER) and progesterone receptor (PgR) ligandbinding assays
(LBAs) are strongly correlated with ER and PgR by immunohistochemistry (IHC). To …
(LBAs) are strongly correlated with ER and PgR by immunohistochemistry (IHC). To …
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a …
PM Ravdin, S Green, TM Dorr, WL McGuire… - Journal of clinical …, 1992 - ascopubs.org
PURPOSE Southwest Oncology Group (SWOG) protocol 8228 is a prospective trial
designed to investigate the prognostic significance of progesterone receptor (PgR) levels in …
designed to investigate the prognostic significance of progesterone receptor (PgR) levels in …
Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer
H Yamashita, Y YAndo, M Nishio, Z Zhang… - Breast cancer, 2006 - jstage.jst.go.jp
Background: The importance of establishing hormone receptor status of tumors for the
treatment of women with hormone receptor-positive breast cancer has been emphasized …
treatment of women with hormone receptor-positive breast cancer has been emphasized …
The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates …
WR Bezwoda, JD Esser, R Dansey, I Kessel, M Lange - Cancer, 1991 - Wiley Online Library
Four hundred fifteen patients with metastatic breast cancer with known hormone receptor
status received primary treatment with tamoxifen. Measured values for the estrogen receptor …
status received primary treatment with tamoxifen. Measured values for the estrogen receptor …
Molecular markers for predicting response to tamoxifen in breast cancer patients
DR Ciocca, R Elledge - Endocrine, 2000 - Springer
Tamoxifen is one of the most effective treatments for breast cancer. Standard practice is to
select patients who are likely to respond to this therapy through the evaluation of estrogen …
select patients who are likely to respond to this therapy through the evaluation of estrogen …
The value of estrogen and progesterone receptors in the treatment of breast cancer
CK Osborne, MG Yochmowitz, WA Knight III… - Cancer, 1980 - Wiley Online Library
The estrogen receptor (ER) assay has become a standard practice in the management of
advanced breast cancer. Tumors lacking ER respond infrequently to endocrine therapy …
advanced breast cancer. Tumors lacking ER respond infrequently to endocrine therapy …
Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy
A Manni, BU Arafah, OH Pearson - Cancer, 1980 - Wiley Online Library
This review presents our experience with the use of estrogen receptors (ER) and
progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV …
progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV …
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
JM Harvey, GM Clark, CK Osborne… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: Immunohistochemistry (IHC) is a newer technique for assessing the estrogen
receptor (ER) status of breast cancers, with the potential to overcome many of the …
receptor (ER) status of breast cancers, with the potential to overcome many of the …
Current status of estrogen and progesterone receptors in breast cancer
WL McGuire, KB Horwitz, OH Pearson, A Segaloff - Cancer, 1977 - Wiley Online Library
Breast cancer is often hormone responsive, since growth or regression of tumors can often
be modulated by appropriate endocrine manipulations. Estrogen and progesterone appear …
be modulated by appropriate endocrine manipulations. Estrogen and progesterone appear …
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer
RJ Broom, PA Tang, C Simmons, L Bordeleau… - Anticancer …, 2009 - ar.iiarjournals.org
Background: Changes in the receptor profile between primary and metastatic breast cancer
tissue have been suggested. The degree of hormone receptor discordance in archival …
tissue have been suggested. The degree of hormone receptor discordance in archival …
相关搜索
- breast cancer progesterone receptor
- progesterone receptor level
- discordance rates progesterone receptor
- estrogen receptor status
- prognostic value steroid receptors
- breast cancer estrogen receptor
- breast cancer receptors in the treatment
- breast cancers steroid receptors
- breast cancer endocrine therapy
- breast cancer prediction of response
- breast cancer discordance rates
- breast cancer prognostic significance
- breast cancers prognostic value
- breast cancer immunohistochemical evaluation
- estrogen receptor level
- discordance rates estrogen receptor